Nephrogen

Seed
nephrogenbiotech.com Biotech & Healthcare New York City, United States 5 employees
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Oct 6, 2026
Investors 5 Backers
Decision Makers 4 Verified

About Nephrogen

Nephrogen is a biotech company developing curative gene therapies for kidney diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters New York City, United States
Team Size 5 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website nephrogenbiotech.com
Domain Registered Date Nov 13, 2015

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

    kidney.org

  2. Milestone

    Website domain registered

    nephrogenbiotech.com

Investors & Backers

5
National Kidney Foundation
StartX (Stanford-StartX Fund)
Techstars
Y Combinator
ZAKA VC

Funding History

2 Rounds
Seed · Oct 6, 2026
Undisclosed kidney.org
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

2

Chang Hong

Chief Business Officer

Work email & phone locked Unlock →

Demetri M.

Co-Founder and CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts